Effect of an exogenous trigger on the pathogenesis of lupus in (NZB × NZW)F1 mice
Open Access
- 9 August 2002
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (8), 2235-2244
- https://doi.org/10.1002/art.10441
Abstract
Objective This study examined the interactions between exogenous and endogenous factors shaping the phenotype of lupus in autoimmune (NZB × NZW)F1 mice exposed to pristane, a model environmental trigger. Methods Frequencies of various autoantibodies in untreated NZB/NZW mice were determined by various means (immunoprecipitation, enzyme‐linked immunosorbent assay [ELISA], Crithidia luciliae kinetoplast staining). Pristane or saline was administered intraperitoneally to 9–12‐week‐old NZB/NZW mice, followed by serial studies of autoantibodies, total Ig levels (ELISA), and proteinuria (dipstick). Results Besides antichromatin/DNA responses, NZB/NZW mice spontaneously produced novel autoantibodies against the double‐stranded RNA binding protein RNA helicase A (RHA). In contrast, NZB/NZW mice (n = 70) did not produce autoantibodies against the nuclear RNP (nRNP), Sm, Ro, or La antigens. Pristane exposure synergistically activated the production of antichromatin/DNA antibodies and dramatically accelerated renal disease. Production of anti‐nRNP/Sm and Su autoantibodies also was induced, indicating that the unresponsiveness of NZB/NZW mice to these antigens can be overcome. Curiously, pristane treatment did not enhance the production of anti‐RHA, suggesting that these autoantibodies are regulated differently than anti‐DNA/chromatin and Sm. In contrast to previous reports that suggest a critical role of deficient interleukin‐12 (IL‐12) production in the pathogenesis of lupus, there was overproduction of IL‐12 in the peritoneal cavity of pristane‐treated NZB/NZW mice, and their spleen cells also produced large amounts of IL‐12. Conclusion These data lead us to propose that environmental influences exacerbate autoimmune manifestations in genetically lupus‐susceptible mice through their stimulatory effects on proinflammatory cytokines, such as IL‐12.Keywords
Funding Information
- USPHS (R01-AR44731, R01-AI44074, R01-AR47322)
This publication has 56 references indexed in Scilit:
- GENETIC SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUSAnnual Review of Immunology, 1998
- Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.Journal of Clinical Investigation, 1998
- Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon γ in the EpidermisThe Journal of Experimental Medicine, 1997
- Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein.Journal of Clinical Investigation, 1996
- Characterization of the Su Antigen, a Macromolecular Complex of 100/102 and 200-kDa Proteins Recognized by Autoantibodies in Systemic Rheumatic DiseasesClinical Immunology and Immunopathology, 1994
- Lipogranulomas and Gold in the Liver in Rheumatoid ArthritisThe American Journal of Surgical Pathology, 1992
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991
- Drug-Related LupusNew England Journal of Medicine, 1988
- In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.The Journal of Experimental Medicine, 1987
- Presence of anti-Sm reactivity in autoimmune mouse strainsThe Journal of Experimental Medicine, 1978